New Insights into Kinase Inhibitors: Accelerating Protein Degradation

Protein kinases are critical molecular switches that regulate various cellular functions, including growth, division, and communication, by attaching phosphate groups to proteins. When these kinases remain in the "on" position, they can contribute to the development of cancer and other diseases. Consequently, kinase inhibitors have emerged as vital therapeutic agents, with over 80 approved by the FDA and many more in clinical trials. Traditionally, these inhibitors were designed to block the enzymatic activity of kinases. However, recent research led by the CeMM Research Center for Molecular Medicine in Vienna, the AITHYRA Institute for Artificial Intelligence in Biomedicine, and the Institute for Research in Biomedicine in Barcelona has revealed that these inhibitors can also accelerate the degradation of the proteins they target.

From Inhibition to Destruction – Kinase Drugs Found to Trigger Protein DegradationFrom inhibition to destruction – kinase drugs found to trigger protein degradationNews-Medical.Net

Published in *Nature*, the study systematically examined 98 kinases using a library of 1,570 inhibitors, revealing that 232 compounds reduced the levels of at least one kinase, affecting 66 different kinases in total. The researchers identified that while some degradation followed the known mechanism of "chaperone deprivation," many instances did not. Instead, the inhibitors were found to induce unstable conformations in kinases, leading to their expedited clearance by the cell's proteolytic systems. Natalie Scholes, a senior postdoctoral researcher at CeMM, noted, “Inhibitor-induced degradation turns out to be surprisingly widespread.”

News-Medical.NetFrom inhibition to destruction – kinase drugs found to trigger protein degradationFrom Inhibition to Destruction – Kinase Drugs Found to Trigger Protein Degradation

To illustrate the mechanisms behind this phenomenon, the researchers focused on three kinases with distinct degradation pathways. The kinase LYN was eliminated within minutes after an inhibitor altered its stability. The kinase BLK was degraded after being released from the cell membrane into the cytosol, while RIPK2 was cleared after forming large protein clusters recognized by the cell's recycling machinery. These examples demonstrate that inhibitors can enhance natural degradation pathways, nudging kinases into unstable states that are subsequently removed by the cell.

News-Medical.NetFrom Inhibition to Destruction – Kinase Drugs Found to Trigger Protein DegradationFrom inhibition to destruction – kinase drugs found to trigger protein degradation

The findings suggest that recognizing protein degradation as a component of kinase inhibitor pharmacology could lead to the design of more effective therapies. Dr. Georg Winter, Director at AITHYRA, emphasized that this understanding could facilitate the development of drugs that not only inhibit kinase activity but also eliminate disease-driving proteins entirely. This approach may also clarify unexpected effects observed in existing therapies.

From inhibition to destruction – kinase drugs found to trigger protein degradation

Dr. Patrick Aloy from IRB Barcelona stated, “These results redefine how we think about kinase inhibitors. Recognising protein degradation as part of their mechanism expands the possibilities for designing therapies that eliminate disease-driving proteins more effectively.” This sentiment reflects a growing recognition of the potential for targeted protein degradation in therapeutic strategies.

From Inhibition to Destruction – Kinase Drugs Found to Trigger Protein Degradation

The study highlights a significant advancement in the understanding of kinase inhibitors, revealing their dual role in both blocking enzymatic activity and promoting protein degradation. This new perspective may pave the way for innovative treatment options in cancer and other diseases, enhancing the efficacy of existing therapies and guiding future drug development efforts.

From inhibition to destruction – kinase drugs found to trigger protein degradation